1 January 2024 false No description of principal activity Taxfiler 2024.6 12792874business:PrivateLimitedCompanyLtd2024-01-012024-12-31 127928742023-12-31 127928742024-01-012024-12-31 12792874business:AuditExemptWithAccountantsReport2024-01-012024-12-31 12792874business:FilletedAccounts2024-01-012024-12-31 127928742024-12-31 12792874business:Director12024-01-012024-12-31 12792874business:RegisteredOffice2024-01-012024-12-31 127928742023-12-31 12792874core:WithinOneYear2024-12-31 12792874core:WithinOneYear2023-12-31 12792874core:AfterOneYear2024-12-31 12792874core:AfterOneYear2023-12-31 12792874core:ShareCapitalcore:PreviouslyStatedAmount2024-12-31 12792874core:ShareCapitalcore:PreviouslyStatedAmount2023-12-31 12792874core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-12-31 12792874core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-12-31 12792874core:PreviouslyStatedAmount2024-12-31 12792874core:PreviouslyStatedAmount2023-12-31 12792874business:SmallEntities2024-01-012024-12-31 12792874countries:EnglandWales2024-01-012024-12-31 12792874core:FurnitureFittings2024-01-012024-12-31 12792874core:ComputerEquipment2024-01-012024-12-31 12792874core:IntangibleAssetsOtherThanGoodwill2023-12-31 12792874core:IntangibleAssetsOtherThanGoodwill2024-12-31 12792874core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-31 12792874core:FurnitureFittings2023-12-31 12792874core:ComputerEquipment2023-12-31 12792874core:FurnitureFittings2024-12-31 12792874core:ComputerEquipment2024-12-31 127928742023-01-012023-12-31 iso4217:GBP xbrli:pure
Company Registration No. 12792874 (England and Wales)
Birmingham Biotech Ltd Unaudited accounts for the year ended 31 December 2024
Birmingham Biotech Ltd Unaudited accounts Contents
Page
- 2 -
Birmingham Biotech Ltd Company Information for the year ended 31 December 2024
Director
Shih-Che (Michael) Hsu
Company Number
12792874 (England and Wales)
Registered Office
Birmingham Research Park 97 Vincent Drive Birmingham B15 2SQ
Accountants
Fosters Accountancy Services (Midlands) Limited Kingsnorth House Blenheim Way Birmingham B44 8LS
- 3 -
Birmingham Biotech Ltd Statement of financial position as at 31 December 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Intangible assets
19,357 
20,135 
Tangible assets
5,004 
3,158 
24,361 
23,293 
Current assets
Debtors
4,500 
19,012 
Cash at bank and in hand
352,090 
175,750 
356,590 
194,762 
Creditors: amounts falling due within one year
(87,469)
(133,197)
Net current assets
269,121 
61,565 
Total assets less current liabilities
293,482 
84,858 
Creditors: amounts falling due after more than one year
(134,970)
(134,970)
Net assets/(liabilities)
158,512 
(50,112)
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
158,412 
(50,212)
Shareholders' funds
158,512 
(50,112)
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 6 June 2025 and were signed on its behalf by
Shih-Che (Michael) Hsu Director Company Registration No. 12792874
- 4 -
Birmingham Biotech Ltd Notes to the Accounts for the year ended 31 December 2024
1
Statutory information
Birmingham Biotech Ltd is a private company, limited by shares, registered in England and Wales, registration number 12792874. The registered office is Birmingham Research Park, 97 Vincent Drive, Birmingham, B15 2SQ.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
These financial statements for the year ended 31 December 2024 are the first financial statements that comply with FRS 102 Section 1A Small Entities. The date of transition is 1 January 2023. The transition to FRS 102 Section 1A Small Entities has resulted in a small number of changes in accounting policies to those used previously. The nature of these changes and their impact on opening equity and profit for the comparative period are explained in the notes below.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
25% reducing balance
Computer equipment
33% straight line
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Other 
£ 
Cost
At 1 January 2024
20,913 
At 31 December 2024
20,913 
Amortisation
At 1 January 2024
778 
Charge for the year
778 
At 31 December 2024
1,556 
Net book value
At 31 December 2024
19,357 
At 31 December 2023
20,135 
- 5 -
Birmingham Biotech Ltd Notes to the Accounts for the year ended 31 December 2024
5
Tangible fixed assets
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 January 2024
2,500 
5,242 
7,742 
Additions
- 
5,786 
5,786 
At 31 December 2024
2,500 
11,028 
13,528 
Depreciation
At 1 January 2024
1,445 
3,139 
4,584 
Charge for the year
264 
3,676 
3,940 
At 31 December 2024
1,709 
6,815 
8,524 
Net book value
At 31 December 2024
791 
4,213 
5,004 
At 31 December 2023
1,055 
2,103 
3,158 
6
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
Trade debtors
- 
9,512 
Other debtors
4,500 
9,500 
4,500 
19,012 
7
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
VAT
604 
5,574 
Trade creditors
9,377 
26,741 
Taxes and social security
64,676 
1,614 
Other creditors
10,727 
13,157 
Loans from directors
1,035 
85,061 
Accruals
1,050 
1,050 
87,469 
133,197 
8
Creditors: amounts falling due after more than one year
2024 
2023 
£ 
£ 
Other creditors
134,970 
134,970 
9
Average number of employees
During the year the average number of employees was 1 (2023: 1).
- 6 -